Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
American Journal of Therapeutics
|
April 17, 2025
Assessment of the Reporting Quality of Randomized Controlled Trials That Investigate the Efficacy of Curcumin for Treating Depression
Alexandra Valera, Theodoros Mprotsis, Chrysoula Doxani
Clinical Therapeutics
|
March 27, 2012
Network analysis of randomized controlled trials in multiple sclerosis
Elias Zintzaras, Chrysoula Doxani, Theodoros Mprotsis, et al.
Sports (Basel, Switzerland)
|
September 26, 2025
Reporting Quality of Meta-Analyses of Randomized Controlled Trials on Knee and Ankle Injury Prevention Programs in Football Players Using PRISMA 2020
Spyridon Plakias, Anna Tsiakiri, Konstantinos Vassis, et al.
Medicina (Kaunas, Lithuania)
|
January 28, 2026
Early Detection of Keratoconus: Diagnostic Advances and Their Impact on Visual Outcomes: A Systematic Review
Evangelos Magklaras, Konstantinia Karamitsou, Vasilios F Diakonis, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
November 10, 2011
Bone mineral density and genetic markers involved in three connected pathways (focal adhesion, actin cytoskeleton regulation and cell cycle): the CUMAGAS-BMD information system
Elias Zintzaras, Chrysoula Doxani, Dimitrios C Ziogas, et al.
Thrombosis Research
|
September 25, 2023
Apixaban reduces the risk of major and clinically relevant non-major bleeding compared to warfarin in patients with end stage renal disease; a systematic review and meta-analysis of ten studies
Konstantinos Zagoridis, Lazaros Karatisidis, Theodoros Mprotsis, et al.
Thrombosis Research
|
May 2, 2024
Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials
Lazaros Karatisidis, Konstantinos Zagoridis, Theodoros Mprotsis, et al.
Frontiers in Clinical Diabetes and Healthcare
|
December 26, 2025
Effectiveness of GLP-1 RAs and SGLT2 inhibitors in preventing T2DM in high-risk patients: an updated systematic review and meta-analysis
Georgios I Tsironikos, Vasiliki Tsolaki, George E Zakynthinos, et al.
Annals of Hematology
|
December 4, 2025
Siltuximab monotherapy improves progression free survival compared to rituximab-based therapies in patients with idiopathic multicentric Castleman disease; indirect comparison of studies using single-arm metanalysis method and the generalized linear mixed model
Lazaros Karatisidis, Theodoros Mprotsis, Stergios Intzes, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2026
Glucagon-like Peptide-1 Receptor Agonists and Platelet Function: Potential Benefits Beyond Glycemic Control
Maria Xanthopoulou, Paschalis Evangelidis, Dimitrios Poulis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
American Journal of Therapeutics
|
April 17, 2025
Assessment of the Reporting Quality of Randomized Controlled Trials That Investigate the Efficacy of Curcumin for Treating Depression
Alexandra Valera, Theodoros Mprotsis, Chrysoula Doxani
Clinical Therapeutics
|
March 27, 2012
Network analysis of randomized controlled trials in multiple sclerosis
Elias Zintzaras, Chrysoula Doxani, Theodoros Mprotsis, et al.
Sports (Basel, Switzerland)
|
September 26, 2025
Reporting Quality of Meta-Analyses of Randomized Controlled Trials on Knee and Ankle Injury Prevention Programs in Football Players Using PRISMA 2020
Spyridon Plakias, Anna Tsiakiri, Konstantinos Vassis, et al.
Medicina (Kaunas, Lithuania)
|
January 28, 2026
Early Detection of Keratoconus: Diagnostic Advances and Their Impact on Visual Outcomes: A Systematic Review
Evangelos Magklaras, Konstantinia Karamitsou, Vasilios F Diakonis, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
November 10, 2011
Bone mineral density and genetic markers involved in three connected pathways (focal adhesion, actin cytoskeleton regulation and cell cycle): the CUMAGAS-BMD information system
Elias Zintzaras, Chrysoula Doxani, Dimitrios C Ziogas, et al.
Thrombosis Research
|
September 25, 2023
Apixaban reduces the risk of major and clinically relevant non-major bleeding compared to warfarin in patients with end stage renal disease; a systematic review and meta-analysis of ten studies
Konstantinos Zagoridis, Lazaros Karatisidis, Theodoros Mprotsis, et al.
Thrombosis Research
|
May 2, 2024
Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials
Lazaros Karatisidis, Konstantinos Zagoridis, Theodoros Mprotsis, et al.
Frontiers in Clinical Diabetes and Healthcare
|
December 26, 2025
Effectiveness of GLP-1 RAs and SGLT2 inhibitors in preventing T2DM in high-risk patients: an updated systematic review and meta-analysis
Georgios I Tsironikos, Vasiliki Tsolaki, George E Zakynthinos, et al.
Annals of Hematology
|
December 4, 2025
Siltuximab monotherapy improves progression free survival compared to rituximab-based therapies in patients with idiopathic multicentric Castleman disease; indirect comparison of studies using single-arm metanalysis method and the generalized linear mixed model
Lazaros Karatisidis, Theodoros Mprotsis, Stergios Intzes, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2026
Glucagon-like Peptide-1 Receptor Agonists and Platelet Function: Potential Benefits Beyond Glycemic Control
Maria Xanthopoulou, Paschalis Evangelidis, Dimitrios Poulis, et al.
Page
of 2